Compare MMYT & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MMYT | RGEN |
|---|---|---|
| Founded | 2000 | 1981 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 8.2B |
| IPO Year | 2010 | N/A |
| Metric | MMYT | RGEN |
|---|---|---|
| Price | $63.97 | $164.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 11 |
| Target Price | $106.33 | ★ $177.18 |
| AVG Volume (30 Days) | ★ 1.3M | 590.3K |
| Earning Date | 01-21-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.53 | 0.03 |
| Revenue | ★ $1,039,337,000.00 | $707,890,000.00 |
| Revenue This Year | $17.65 | $17.86 |
| Revenue Next Year | $17.64 | $12.44 |
| P/E Ratio | ★ $120.11 | $6,419.08 |
| Revenue Growth | 11.07 | ★ 11.74 |
| 52 Week Low | $62.01 | $102.97 |
| 52 Week High | $120.73 | $182.52 |
| Indicator | MMYT | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 25.26 | 46.62 |
| Support Level | $62.01 | $160.22 |
| Resistance Level | $75.13 | $174.87 |
| Average True Range (ATR) | 3.04 | 6.84 |
| MACD | -1.83 | -0.67 |
| Stochastic Oscillator | 8.80 | 27.39 |
MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.